The mechanism of suicidal inactivation of lactoperoxidase (LPO) by mercaptomethylimidazole (MMI) has been studied. Analogue studies indicate a specific requirement for the thiol group of MMI for inactivation of LPO in the presence of H202' MMI is oxidized via one-electron transfer by LPO compound II as demonstrated by a spectral shift from 430 to 412 nm through an isosbestic point at 421 nm. A decrease in Soret absorbance at 412 nm and the appearance ofvisible peaks at 592 and 636 nm are the characteristics of the inactivated enzyme. The one-electron oxidation product of MMI was identified by e.s.r. spectroscopy as the 5,5'-dimethyl-l-pyrroline N-oxide (DMPO) adduct of the sulphur-centred thiyl radical. Both inactivation and spectral change are prevented by the radical-tr-ap. DMPO, suggesting INTRODUCTION 
INTRODUCTION
The mechanism of inactivation of thyroid peroxidase (TPO) and lactoperoxidase (LPO) by mercaptomethylimidazole (MMI), a potent antithyroid drug of the thionamide group, has been a subject of continuous research for the past three decades (Moris and Hager, 1966; Taurog, 1976; Davidson et al., 1978; Michot et al., 1979; Edelhoch et al., 1979; Engler et al., 1982; Ohtaki et al., 1982; Nakamura et al., 1984; Doerge, 1986a,b; Mason and Ramakrishna Rao, 1990) . Inhibition of TPO by MMI is either reversible or irreversible depending on the ratio of iodide to drug (Taurog, 1976) . Kinetic, spectral and radiolabelled drug-binding studies indicate that MMI irreversibly inactivates the enzyme by interacting with the haem of the oxidized TPO, and low concentrations of iodide protect it by keeping the enzyme (TPO-I10.) in the reduced state, conditions under which MMI does not bind (Engler et al., 1982) . That a reactive oxidation product of MMI interacts with the haem to cause inactivation (Engler et al., 1982) was also previously postulated (Davidson et al., 1978) . As LPO resembles TPO (Carlstr6m, 1969; Taurog et al., 1974; Ohtaki et al., 1982) , the mechanism of inactivation was further studied with this enzyme. MMI is directly oxidized by the LPO-H202 system at a lower rate, and iodide increases the rate of drug oxidation and decreases the inactivation of LPO without changing the binding constant of MMI . MMI was also shown to accelerate the reduction of both TPO and LPO compound I to compound II via one-electron transfer, and inactivation was found to be due to reaction of MMI with compound II to form an adduct (Ohtaki et al., 1982) . This involvement of the thiyl radical in inactivation. pH-dependent inactivation kinetics indicate the involvement of an ionizable group on LPO (pK. 6.1), deprotonation of which favours inactivation. The enzyme is protected by iodide and not by guaiacol, suggesting that MMI interacts at or near the iodidebinding site which is away from the aromatic-donor-binding site. The inactive enzyme can form compound II and bind aromatic donor, indicating that the MMI oxidation product does not attack haem iron or aromatic-donor-binding site. We suggest that MMI interacts at the iodide-binding site for oxidation and the reactive product, probably the thiyl radical, is incorporated into the adjacent electron-rich site of haem porphyrin to cause inactivation.
adduct was later characterized as a 'sulphlactoperoxidase' with stable visible peaks at 592 and 636 nm (Nakamura et al., 1984) .
However, the yield of the adduct was only 20 % whereas 80 % of LPO compound II was reduced to the ferric state by one-electron transfer (Nakamura et al., 1984) forming the free radical of MMI. Doerge (1986a) presented kinetic evidence for suicidal (mechanism-based) inactivation of LPO by MMI and suggested that the sulphoxygenation reaction between LPO compound II and MMI produces a reactive MMI intermediate which interacts with the haem to cause inactivation.
The plausible role of the reactive free radical of MMI (Ohtaki et al. 1982; Nakamura et al., 1984) in the inactivation of TPO and LPO has been ignored, as catalytic oxidation may not proceed because of concurrent inactivation of the enzyme. If 12% of MMI is oxidized by the LPO-H202 system and about 100 mol of MMI is turned over per mol of LPO , the amount of free radical generated should be sufficient to kill the enzyme. The role of this free radical therefore remains to be investigated, especially as a view is emerging that peroxidasecatalysed oxidation of some substrates generates highly reactive free radicals which cause suicidal inactivation of the enzyme by incorporation into haem (Sinha, 1982; Ortiz de Montellano, 1987; Ortiz de Montellano et al., 1988) . MMI may also undergo a partial sulphoxidation reaction with LPO compound II (Nakamura et al., 1984) , and Doerge et al. (1993) attempted to identify the product as imidazole-2-sulphenic acid by chemical oxidation of some MMI analogues with 3-chloroperbenzoic acid, although significant differences may exist in the chemical and enzymic oxidation products. Doerge also suggested Abbreviations used: MMI, 1 -methyl-2-mercaptoimidazole; LPO, lactoperoxidase; TPO, thyroid peroxidase; DETAPAC, diethylenetriaminepenta-acetic acid; DMPO, 5,5'-dimethyl-1-pyrroline N-oxide. the possible role ofthis sulphoxidation product (Doerge, 1986a (Doerge, ,b, 1988 Doerge et al., 1993) but direct evidence for imidazole-2-sulphenic acid as the reactive MMI intermediate is still lacking.
Here we present direct evidence for the formation of a sulphurcentred MMI thiyl radical by univalent oxidation of MMI by LPO compound II and its role in enzyme inactivation via interaction with the haem. Specific protection by halide and not by aromatic donor has provided further insight into the spatial relationship of the binding sites of these electron donors at the haem periphery of LPO. EXPERIMENTAL LPO (A412/A280 = 0.8), MMI, 2-mercaptoimidazole, imidazole, 1-methylimidazole, resorcinol, guaiacol and diethylenetriaminepenta-acetic acid (DETAPAC) were obtained from Sigma. 5,5'-Dimethyl-1-pyrroline N-oxide (DMPO) was from Aldrich. LPO concentration was determined by using 6412 = 114 cm-' -mM-1 (Morrison and Bayse, 1970) .
Kinetic and spectrophotometric measurements were performed at 25 + 1 C in a Shimadzu UV-2201 spectrophotometer. Peroxidase activity was measured using iodide or guaiacol as electron donor (Alexander 1962; Banerjee et al., 1986; De and Banerjee, 1986; Bandyopadhyay et al., 1992; Bhattacharyya et al., 1993) .
Enzyme activity was expressed as nmol of I3-or nmol of tetraguaiacol formed/min, calculated from molar and millimolar absorption coefficients of I3-and tetraguaiacol of 26 340 (Huwiler and Kohler, 1984) and 6.48 (Hosoya, 1960) respectively.
Inactivation of LPO
Inactivation of LPO by MMI or its analogues was carried out in a 30,l preincubation mixture containing LPO (10 nM), H202 (100,M), MMI (3 ,M) and sodium phosphate buffer (50 mM, pH 7.2) for 3 min at 25 + 1 'C. Peroxidase activity was finally assayed by measuring iodide oxidation or guaiacol oxidation. For iodide oxidation, whole preincubation mixture was transferred to a 1 ml iodide assay solution containing sodium acetate buffer (50 mM, pH 5.2), KI (1.7 mM) and H202 (0.27 mM). For guaiacol oxidation, preincubation mixture was transferred to a 1 ml guaiacol assay solution containing sodium phosphate buffer (50 mM, pH 7.2), guaiacol (20 mM) and H202 (0.27 mM). To measure substrate protection against inactivation, electron donors were added to the preincubation mixture before the addition of MMI Under these conditions, the enzyme showed complete loss of activity with 70% reduction of its Soret peak at 412 nm. The reaction mixture was then passed through a Sephadex G-25 spin column to remove small molecules. Spectral studies using control and modified enzyme were carried out in a Shimadzu UV-2201 spectrophotometer in a 1 ml cuvette of I cm light path. The difference spectra of the MMI-modified LPO-resorcinol complex versus the modified LPO and the native LPO-resorcinol complex versus native LPO were recorded as described previously (Hosoya et al., 1989; Bhattacharyya et al., 1993) . Initially, both the sample and reference cuvettes were filled with 1 ml of enzyme solution, and a baseline trace were recorded. A small volume (usually 5-20 1l) of the donor solution of appropriate concentration was then successively added to the sample cuvette with concomitant addition of the same volume of buffer to the reference cuvette. The contents of each cuvette were stirred well with a plastic rod before the difference spectrum was recorded.
RESULTS

Involvement of the SH group of MMI in inactivation
We have observed that MMI acts as a suicidal substrate and inactivates LPO following mechanism-based kinetics (results not shown) similar to those of gastric peroxidase . In order to ascertain which group in MMI is essential for inactivation, the effect of various MMI analogues was investigated in the presence or absence of H202' The results (Table 1) indicate that LPO loses its ability to oxidize iodide and guaiacol when preincubated with MMI and H202 together. No inactivation occurs in absence of H2025 indicating that either catalytically active enzyme is prone to inactivation by MMI or MMI is oxidized by catalytically active LPO to an inactivating species which concurrently kills the enzyme. 2-Mercaptoimidazole which is devoid of the methyl group is equally effective. On the other hand, 1-methylimidazole which is devoid of the SH group is not effective at all. Imidazole has no effect. Thus the SH group of MMI appears to be essential for inactivation of catalytically active LPO. Evidence for one-electron oxidation of MMI As MMI acts as a suicidal substrate to LPO, it must be oxidized by the catalytically active LPO before inactivation. Figure 1 shows the spectral change in LPO compound II (Figure 2 , spectrum A) was due to formation of spin-trapped MMI thiyl radical with hyperfine splitting constants of aN = 15 G, a/H = 3.2 G which are consistent with the splitting constants of the known DMPO-thiyl radical adduct (Mottley et al., 1987) . In the absence of H202 (Figure 2, Figure 5a ), a straight line is obtained, the slope of which gives a PKa value of 6.1 (Figure 5b) . It thus appears that ionization of a group on the enzyme with PKa 6.1 greatly enhances the rate of inactivation. As the PKa of thiolimidazole is 10.8 (Stowell, 1961) , the role of MMI ionization at the pH range of inactivation is too small to be excluded.
Specfflc protection of LPO against MMI inactivation by halides
The irreversible inactivation of LPO by MMI Electron donors were added betore the addition ot MMI (3 1sM) and H202 (100 ,uM) in the preincubation system containing LPO (0.01 ,uM) in 50 mM sodium phosphate buffer, pH 7.2, in a final volume ot 50t,u. In each case, remaining peroxidase activity was assayed 3 min after the addition of H202 by tollowing iodide oxidation as described in the Experimental section.
A, Control;@*, +20 uM l-; O, +20OisM Br-; *, +10,uM l-; 2, +5,uM lx, +2.5 ,uM l-; @, +10 mM guaiacol; A\ +10 mM resorcinol; V, control +MMI. The preincubation system is the same as that described in the legend of Figure 6 and is a saturable process. The difference between the two types of substrate in protecting the enzyme against inactivation under identical preincubation conditions was further confirmed by assaying the activity at both pH 7.2 and 5.2 using guaiacol and iodide as electron donor. The results in Table 2 indicate that, whereas iodide protects LPO by 90-100%, guaiacol offers no 400 500 600 700 Wavelength (nm) protection at all, as demonstrated by assay of both guaiacol and iodide oxidation at two different pH values.-Spectral studies further indicate that, in the presence of iodide, MMI is unable to interact with the enzyme, as shown by the absence of any decrease in Soret spectrum at 412 nm (Figure 7a ) and the lack of appearance of visible bands at 592 and 636 nm (not shown), whereas, in the presence of guaiacol, the enzyme shows typical MMI-induced spectral change at 412 nm characteristic of inactivation (Figure 7b ). Specific protection by iodide suggests that MMI interacts at or near the iodide-binding site but not at the binding site of the aromatic donor for oxidation.
Absence of Interaction of MMI oxidation product with the haem iron or aromatic-donor-binding site In order to discover whether the MMI oxidation product binds the haem iron, LPO was inactivated with H202 and MMI, and spectral studies were carried out to detect compound-I1 formation after removal of the small molecules through a spin column of Sephadex G-25. Figure 8(a) shows that MMI-inactivated enzyme can readily form compound II absorbing at 430 nm with H202.
This indicates that haem iron remains free in the ferric state, and the interaction of the MMI oxidation product elsewhere does not interfere with the reactivity of the enzyme with H202 which is required for donor oxidation.
It is possible that the enzyme is inactivated because of interaction of the product at the substrate-binding site. To investigate this, aromatic-donor binding was studied by difference spectroscopy using resorcinol as substrate. The difference spectrum of native LPO-resorcinol complex versus LPO (Figure 8b) shows a peak at 427 nm and a trough at 407 nm indicating binding of resorcinol to LPO (Hosoya et al., 1989 oxidation product must interact at the haem site away from the iron centre but close to the iodide-and aromatic-donor-binding sites to cause inactivation of LPO.
DISCUSSION
Evidence has been presented to show that MMI is oxidized to a highly reactive free radical before irreversibly inactivating LPO. Spectral data suggest that MMI is oxidized by LPO compound II which is reduced to the ferric state by a one-electron-transfer mechanism (Ohtaki et al., 1982; Nakamura et al., 1984) . Re (Mottley et al., 1987) , we suggest that the oxidation product is a sulphur-centred thiyl radical (Dunford, 1982; Harman et al., 1984; Mottley et al., 1987; Mason and Ramakrishna Rao, 1990) . It is evident that MMI radical and not MMI is involved in the inactivation because DMPO, a free-radical trap, prevents both inactivation and associated spectral change. If MMI were the species that reacted with compound II (Doerge, 1986a,b) , both inactivation and spectral change would have occurred in the presence of DMPO. It is possible that MMI disulphide or another secondary product generated from the thiyl radical (Taurog et al., 1989) might be the active species but, as a radical is more reactive than the stable product, inactivation by the thiyl radical is the more plausible mechanism. Moreover, MMI acts as a suicidal substrate for LPO (Doerge, 1986a,b) , and suicidal substrates ofperoxidases are now known to inactivate via generation of a more reactive radical which interacts with the specific haem site to block electron transfer (Ortiz de Montellano, 1987; Ortiz de Montellano et al., 1988; Hosoya et al., 1989) . The pHdependence of inactivation of LPO indicates the requirement for an ionizable group of pKa 6.1 on the enzyme, deprotonation of which favours inactivation. As distal histidine in the haem pocket of LPO exhibits a PKa value around 6 and is involved in the binding of halide (Sakurada et al., 1987) and pseudohalide (Modi et al., 1989) , we suggest that this residue may control inactivation by influencing the binding and oxidation of MMI.
MMI reversibly inhibits the catalytic activity of chloroperoxidase (Moris and Hager, 1966) , horseradish peroxidase and prostaglandin synthetase-peroxidase (Petry and Eling, 1987) but irreversibly inactivates TPO (Engler et al., 1982) , LPO (Doerge, 1986a,b) and gastric peroxidase . In the latter three, MMI presumably binds at the active site as a substrate whereas in the former it may react with the substrate free-radical intermediate or the product (Moris and Hager, 1966; Petry and Eling, 1989 ) without binding at the active site. Substrate protection against inactivator usually sheds more light on the nature, location, orientation and mode of interaction of both substrate and inhibitor at the active site. Inactivation of LPO is prevented specifically by iodide (halide) and not by guaiacol (aromatic donor). Although both are electron donors, the specific protection by iodide indicates that MMI interacts at or near the iodide-binding site and not at the guaiacol-binding site. In the presence of iodide, MMI neither binds nor is oxidized to inactivate the enzyme whereas, in the presence of guaiacol, it binds to the iodide-binding site, competes with guaiacol for oxidation and the reactive product formed concurrently inactivates the enzyme. It is also possible that the LPO-catalysed primary oxidation product of iodide either in the free state (II) or in the enzyme-bound state (EOI) may oxidize MMI so that I+ is reduced to l- (Taurog, 1976) . This cyclic process may maintain a large enough 1-concentration at the active site of LPO to prevent MMI binding for oxidation. Although MMI-inactivated enzyme can form compound II and bind aromatic donor, it cannot oxidize it because the MMI oxidation product attacks a specific haem site which must be very close to both iodide-and aromatic-donor-binding sites and through which electrons from the donors are transferred to the haem ferryl group. The spatial alignment of iodide-binding and aromatic-donor-binding sites in LPO is still obscure. Proton and 1271 n.m.r. studies indicate that iodide binds to LPO in the vicinity of the haem methyl protons but close enough to interact with the distal histidine residue which possibly mediates electron transport in iodide oxidation (Sakurada et al., 1987) . Iodide significantly increases the KD value of resorcinol binding, suggesting a close proximity of iodide-binding and aromatic-donor-binding sites (Sakurada et al., 1987; Hosoya et al., 1989; Modi et al., 1989) . Our studies on the specific protection of LPO by iodide and not by guaiacol indicate that the iodide-and MMI-binding sites are the same or very close to each other but away from the aromatic-donorbinding site. As resorcinol binding in MMI-inactivated enzyme is slightly perturbed compared with that of the native enzyme, the reactive oxidation product appears to interact at a specific haem site close to the aromatic-donor-binding site. We therefore conclude that MMI interacts at or near the iodide-binding site of LPO compound II and is oxidized by one-electron transfer to form the thiyl radical which either directly or indirectly (through generation of a secondary product) inactivates the ferric enzyme by incorporation into a specific site of the haem prosthetic group. U.B. gratefully acknowledges the award of a fellowship from the University Grants Commission (UGC) during this work.
